On September 6, 2023 HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, reported that HOOKIPA’s management team will participate in and present at the following upcoming investor conferences (Press release, Hookipa Pharma, SEP 6, 2023, View Source [SID1234634943]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Morgan Stanley Global Healthcare Conference, September 11-13, New York
Fireside Chat: Monday, September 11, 3:35pm ET

H.C. Wainwright Global Investment Conference, September 11-13, New York
Fireside Chat: Tuesday, September 12, 11:30am ET

In addition to the presentations, HOOKIPA will also host one-on-one investor meetings.